Stockholm, Sweden - May 24, 2017 -  Karin Bernadotte, member of the board of ContextVision AB, has purchased 2 000 shares in ContextVision AB.

On May 23rd 2017 Karin Bernadotte purchased 2 000 shares at an average price of NOK 58,00. Following this transaction Karin Bernadotte owns 8 500 shares in ContextVision AB.

"ContextVision has started to develop in a new direction and I see a great potential for future growth" comments Karin Bernadotte.

For inquires please contact CEO Anita Tollstadius;
anita.tollstadius@contextvision.se

---
About ContextVision
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. As an industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology. ContextVision is currently investing significantly in the field to expand its product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit http://www.contextvision.com.

ContextVision - share purchase


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ContextVision AB via Globenewswire